Department of Neurosurgery
Joy Gumin has not added Biography.
If you are Joy Gumin and would like to personalize this page please email our Author Liaison for assistance.
REST regulates oncogenic properties of glioblastoma stem cells.
Stem cells (Dayton, Ohio) Mar, 2012 | Pubmed ID: 22228704
TGF-β mediates homing of bone marrow-derived human mesenchymal stem cells to glioma stem cells.
Cancer research Apr, 2013 | Pubmed ID: 23365134
Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma.
Oncogene Mar, 2015 | Pubmed ID: 24747968
Delta-24-RGD oncolytic adenovirus elicits anti-glioma immunity in an immunocompetent mouse model.
PloS one , 2014 | Pubmed ID: 24827739
ESI-MS/MS and MALDI-IMS Localization Reveal Alterations in Phosphatidic Acid, Diacylglycerol, and DHA in Glioma Stem Cell Xenografts.
Journal of proteome research Jun, 2015 | Pubmed ID: 25880480
Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway.
Stem cells (Dayton, Ohio) Aug, 2015 | Pubmed ID: 25966666
Integrated Transcriptomic and Glycomic Profiling of Glioma Stem Cell Xenografts.
Journal of proteome research Sep, 2015 | Pubmed ID: 26185906
Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas.
Oncotarget Mar, 2016 | Pubmed ID: 26910374
Critical Role of Autophagy in the Processing of Adenovirus Capsid-Incorporated Cancer-Specific Antigens.
PloS one , 2016 | Pubmed ID: 27093696
A Dexamethasone-regulated Gene Signature Is Prognostic for Poor Survival in Glioblastoma Patients.
Journal of neurosurgical anesthesiology Jan, 2017 | Pubmed ID: 27653222
Preclinical Evaluation of Sequential Combination of Oncolytic Adenovirus Delta-24-RGD and Phosphatidylserine-Targeting Antibody in Pancreatic Ductal Adenocarcinoma.
Molecular cancer therapeutics Apr, 2017 | Pubmed ID: 28138026
Ionizing radiation augments glioma tropism of mesenchymal stem cells.
Journal of neurosurgery Jan, 2018 | Pubmed ID: 28362237
Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination with Temozolomide against Malignant Gliomas.
Clinical cancer research : an official journal of the American Association for Cancer Research Oct, 2017 | Pubmed ID: 28679777
Mesenchymal stem cells as natural biofactories for exosomes carrying miR-124a in the treatment of gliomas.
Neuro-oncology Feb, 2018 | Pubmed ID: 29016843
Dexamethasone-mediated oncogenicity in vitro and in an animal model of glioblastoma.
Journal of neurosurgery Dec, 2018 | Pubmed ID: 29328002
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology May, 2018 | Pubmed ID: 29432077
Magnetic resonance and photoacoustic imaging of brain tumor mediated by mesenchymal stem cell labeled with multifunctional nanoparticle introduced via carotid artery injection.
Nanotechnology Apr, 2018 | Pubmed ID: 29438105
Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes.
Oncoimmunology , 2018 | Pubmed ID: 29632728
A gene expression signature predicts recurrence-free survival in meningioma.
Oncotarget Mar, 2018 | Pubmed ID: 29662628
A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
Clinical cancer research : an official journal of the American Association for Cancer Research Dec, 2018 | Pubmed ID: 30054278
REST overexpression in mice causes deficits in spontaneous locomotion.
Scientific reports Aug, 2018 | Pubmed ID: 30108242
REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis.
Neuro-oncology Jun, 2019 | Pubmed ID: 30953587
Microcatheter delivery of neurotherapeutics: compatibility with mesenchymal stem cells.
Journal of neurosurgery Sep, 2019 | Pubmed ID: 31491769
GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memory.
Neuro-oncology advances , 2019 | Pubmed ID: 31608328
Advances in endovascular neuro-oncology: endovascular selective intra-arterial (ESIA) infusion of targeted biologic therapy for brain tumors.
Journal of neurointerventional surgery Feb, 2020 | Pubmed ID: 31676690
RNAi technology targeting the fusion breakpoint: an opportunity for precision medicine.
Neuro-oncology advances , 2020 | Pubmed ID: 33241214
Medium-Chain Acyl-CoA Dehydrogenase Protects Mitochondria from Lipid Peroxidation in Glioblastoma.
Cancer discovery Nov, 2021 | Pubmed ID: 34039636
An immune-competent, replication-permissive Syrian Hamster glioma model for evaluating Delta-24-RGD oncolytic adenovirus.
Neuro-oncology Nov, 2021 | Pubmed ID: 34059921
Targeting the αv integrin/TGF-β axis improves natural killer cell function against glioblastoma stem cells.
The Journal of clinical investigation Jul, 2021 | Pubmed ID: 34138753
Characterization of patient-derived bone marrow human mesenchymal stem cells as oncolytic virus carriers for the treatment of glioblastoma.
Journal of neurosurgery Mar, 2022 | Pubmed ID: 34450587
Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic Resonance.
Cells Oct, 2021 | Pubmed ID: 34685601
Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry.
Journal for immunotherapy of cancer Jul, 2022 | Pubmed ID: 35902132
Author Correction: REST overexpression in mice causes deficits in spontaneous locomotion.
Scientific reports Dec, 2022 | Pubmed ID: 36526687
A Case Study of Chimeric Antigen Receptor T Cell Function: Donor Therapeutic Differences in Activity and Modulation with Verteporfin.
Cancers Feb, 2023 | Pubmed ID: 36831427
Comparison of pharmacological inhibitors of lysine-specific demethylase 1 in glioblastoma stem cells reveals inhibitor-specific efficacy profiles.
Frontiers in neurology , 2023 | Pubmed ID: 37082446
Adjuvant Therapy with Oncolytic Adenovirus Delta-24-RGDOX After Intratumoral Adoptive T-cell Therapy Promotes Antigen Spread to Sustain Systemic Antitumor Immunity.
Cancer research communications Jun, 2023 | Pubmed ID: 37379361
Multiomics analyses reveal /YBX1-controlled posttranscriptional circuits promoting glioblastoma tumorigenesis/radioresistance.
Science advances Aug, 2023 | Pubmed ID: 37540752
Tumor-specific polycistronic miRNA delivered by engineered exosomes for the treatment of glioblastoma.
Neuro-oncology Feb, 2024 | Pubmed ID: 37847405
Triggering receptor expressed on myeloid cells 2 (TREM2) regulates phagocytosis in glioblastoma.
Neuro-oncology Jan, 2024 | Pubmed ID: 38237157
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados